scispace - formally typeset
Journal ArticleDOI

Human antibody-Fc receptor interactions illuminated by crystal structures.

TLDR
The structural information that is emerging on three human immunoglobulin classes and their FcRs is reviewed, including an understanding of the antibody conformational adjustments that are required to bring effector cell and target cell membranes sufficiently close for efficient killing and signal transduction to occur.
Abstract
Immunoglobulins couple the recognition of invading pathogens with the triggering of potent effector mechanisms for pathogen elimination. Different immunoglobulin classes trigger different effector mechanisms through interaction of immunoglobulin Fc regions with specific Fc receptors (FcRs) on immune cells. Here, we review the structural information that is emerging on three human immunoglobulin classes and their FcRs. New insights are provided, including an understanding of the antibody conformational adjustments that are required to bring effector cell and target cell membranes sufficiently close for efficient killing and signal transduction to occur. The results might also open up new possibilities for the design of therapeutic antibodies.

read more

Citations
More filters
Journal ArticleDOI

Engineered antibody fragments and the rise of single domains

TL;DR: There is tremendous potential for all antibody fragments either as robust diagnostic reagents, or as nonimmunogenic in vivo biopharmaceuticals with superior biodistribution and blood clearance properties.
Journal ArticleDOI

Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses

TL;DR: The results document how hFcgammaR specificity and affinity may account for the biological activities of antibodies and highlight the role of specific hF cgammaRs in the therapeutic and pathogenic effects of antibodies in disease.
Journal ArticleDOI

Glycosylation as a strategy to improve antibody-based therapeutics

TL;DR: Current knowledge of methods and avenues for their exploitation in the clinic are summarized, which allow the production of rMAbs bearing pre-selected oligosaccharides — glycoforms — to provide maximum efficacy for a given disease indication.
Journal ArticleDOI

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

TL;DR: How direct targeting of antigens to DC surface receptors in vivo might replace laborious and expensive ex vivo culturing, and facilitate large-scale application of DC-based vaccination therapies is discussed.
Journal ArticleDOI

The function of immunoglobulin A in immunity

TL;DR: Current understanding of the roles played by IgA in both health and disease is detailed, with a focus on the role of mucosal surfaces.
References
More filters
Journal ArticleDOI

Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity

TL;DR: Antibody-dependent cellular cytot toxicity assays using purified peripheral blood monocytes or natural killer cells from several donors showed enhanced cytotoxicity, especially evident at lower antibody concentrations.
Journal ArticleDOI

The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity.

TL;DR: The results indicate that the lack of fucosylation of IgG1 has the most critical role in enhancement of ADCC, although several reports have suggested the importance of Gal or bisecting GlcNAc and provide important information to produce the effective therapeutic antibody.
Journal ArticleDOI

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

TL;DR: The model of human Fc fragment was refined at 2.9-A resolution and the R value of the model is 0.24, with strong arguments that contact 1 is the fragment B-Fc contact formed in solution under physiological conditions, while contact 2 is a crystal contact.
Journal ArticleDOI

Antigen receptor tail clue.

Michael Reth
- 30 Mar 1989 - 
Journal ArticleDOI

A new member of the immunoglobulin superfamily--CTLA-4.

TL;DR: CTLA-4 is mainly expressed in activated lymphocytes and is coinduced with T-cell-mediated cytotoxicity in inducible models of this process and could encode a 223-amino-acid protein clearly belonging to the immunoglobulin superfamily.
Related Papers (5)